ProQR Therapeutics NV (PRQR)
1.94
+0.02
(+1.04%)
USD |
NASDAQ |
May 17, 16:00
1.94
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics Free Cash Flow: -43.28M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -43.28M |
| December 31, 2023 | 21.84M |
| September 30, 2023 | 7.199M |
| June 30, 2023 | 2.142M |
| March 31, 2023 | -1.864M |
| December 31, 2022 | -72.99M |
| September 30, 2022 | -47.69M |
| June 30, 2022 | -43.17M |
| March 31, 2022 | -40.38M |
| December 31, 2021 | -31.35M |
| September 30, 2021 | -48.01M |
| June 30, 2021 | -52.43M |
| March 31, 2021 | -52.23M |
| December 31, 2020 | -54.80M |
| September 30, 2020 | -56.12M |
| June 30, 2020 | -52.09M |
| March 31, 2020 | -52.36M |
| December 31, 2019 | -49.87M |
| September 30, 2019 | -47.11M |
| Date | Value |
|---|---|
| June 30, 2019 | -42.18M |
| March 31, 2019 | -36.38M |
| December 31, 2018 | -34.01M |
| September 30, 2018 | -31.62M |
| June 30, 2018 | -37.41M |
| March 31, 2018 | -42.25M |
| December 31, 2017 | -39.72M |
| September 30, 2017 | -38.86M |
| June 30, 2017 | -40.75M |
| March 31, 2017 | -40.97M |
| December 31, 2016 | -40.68M |
| September 30, 2016 | -40.51M |
| June 30, 2016 | -35.35M |
| March 31, 2016 | -30.98M |
| December 31, 2015 | -28.36M |
| September 30, 2015 | -28.17M |
| June 30, 2015 | -26.97M |
| March 31, 2015 | -24.50M |
| December 31, 2014 | -20.87M |
Free Cash Flow Range, Past 5 Years
-72.99M
Minimum
Dec 2022
21.84M
Maximum
Dec 2023
-37.84M
Average
-47.40M
Median
Free Cash Flow Benchmarks
| uniQure NV | -135.36M |
| Merus NV | -150.28M |
| argenx SE | -- |
| Pharming Group | -3.493M |
| Pharvaris NV | -100.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.44M |
| Cash from Investing (Quarterly) | -19.26M |
| Cash from Financing (Quarterly) | -0.4551M |
| Free Cash Flow Per Share (Quarterly) | -0.2112 |
| Free Cash Flow to Equity (Quarterly) | -17.20M |
| Free Cash Flow to Firm (Quarterly) | -17.23M |
| Free Cash Flow Yield | -27.48% |